In the same period a year ago the company posted earnings of $1.40 a share on sales of $1.9 billion.
The stock has fallen 6.3% since the company last reported earnings on Oct. 23.
Quarterly estimates have fallen less than 1 cent a share in the past month. Quest Diagnostics is currently trading at a price-to-forward-earnings ratio of 13.6 based on the 12-month estimates of 19 analysts surveyed by FactSet.
Jim Cramer and the AAP team are watching the healthcare providers & services sector. To find out more about what stocks they like in the industry click here now.